In response to the outbreak of the Ebola virus in West Africa, Oxford University Press has made more than 50 articles from leading journals and online resources freely accessible to assist researchers, medical professionals, policy makers, and others working on the containment, treatment, and prevention of Ebola hemorrhagic fever. UPDATED: Articles are free to access worldwide until 4 January 2016.
Click on the arrows below to view articles from our journals and online resources.
Se-Ran Jun, Michael R. Leuze, Intawat Nookaew, Edward C. Uberbacher, Miriam Land, Qian Zhang, Visanu Wanchai, Juanjuan Chai, Morten Nielsen, Thomas Trolle, Ole Lund, Gregory S. Buzard, Thomas D. Pedersen, Trudy M. Wassenaar, David W. Ussery
14 July 2015
How the current West African Ebola epidemic is altering views on the need for vaccines and is galvanizing a global effort to field test leading candidates
Myron M. Levine, Milagritos Tapia, Adrian V. Hill, et al.
14 September 2014, Advance Access
DNA Vaccines Encoding Ebolavirus and Marburgvirus Wild Type Glycoproteins are Safe and Immunogenic in a Phase I Clinical Trial
Uzma N. Sarwar, Pamela Costner, Mary E. Enama, et al.
14 September 2014, Advance Access
A Practical Treatment for Patients with Ebola Virus Disease
David S. Fedson
25 August 2014; Advance Access
Reply to Fedson
Anita K. McElroy and Christina F Spiropoulou
25 August 2014; Advance Access
Ebola Hemorrhagic Fever: Novel Biomarker Correlates of Clinical Outcome
Anita K. McElroy, Bobbie R. Erickson, Timothy D. Flietstra, et al.
15 August 2014; 210 (4): 558 - 566
Interferon-β Therapy Prolongs Survival in Rhesus Macaque Models of Ebola and Marburg Hemorrhagic Fever
Lauren M. Smith, Lisa E. Hensley, Thomas W. Geisbert, et al.
15 July 2013; 208 (2): 310 - 318
A Syrian Golden Hamster Model Recapitulating Ebola Hemorrhagic Fever
Hideki Ebihara, Marko Zivcec, Donald Gardner, et al.
15 January 2013; 207 (2): 306 - 318
Reston ebolavirus in Humans and Animals in the Philippines: A Review
Mary Elizabeth G. Miranda and Noel Lee J. Miranda
1 November 2011; 204: S757 - S760
Management of Accidental Exposure to Ebola Virus in the Biosafety Level 4 Laboratory, Hamburg, Germany
Stephan Günther, Heinz Feldmann, Thomas W. Geisbert, et al.
1 November 2011; 204: S785 - S790
Ebola Reston Virus Infection of Pigs: Clinical Significance and Transmission Potential
Glenn A. Marsh, Jessica Haining, Rachel Robinson, et al.
1 November 2011; 204: S804 - S809
Basic Clinical and Laboratory Features of Filoviral Hemorrhagic Fever
Mark G. Kortepeter, Daniel G. Bausch, and Mike Bray
1 November 2011; 204: S810 - S816
Characterization of Filovirus Protein–Protein Interactions in Mammalian Cells Using Bimolecular Complementation
Yuliang Liu, Sasha Stone, and Ronald N. Harty
1 November 2011; 204: S817 - S824
Comparative Analysis of Ebola Virus Glycoprotein Interactions With Human and Bat Cells
Annika Kühl, Markus Hoffmann, Marcel A. Müller, et al.
1 November 2011; 204: S840 - S849
DRBP76 Associates With Ebola Virus VP35 and Suppresses Viral Polymerase Function
Reed S. Shabman, Daisy W. Leung, Joshua Johnson, et al.
1 November 2011; 204: S911 - S918
Real-time Monitoring of Cardiovascular Function in Rhesus Macaques Infected With Zaire ebolavirus
Mark G. Kortepeter, James V. Lawler, Anna Honko et al.
1 November 2011; 204: S1000 - S1010
The Importance of the NP: VP35 Ratio in Ebola Virus Nucleocapsid Formation
Takeshi Noda, Larissa Kolesnikova, Stephan Becker, et al.
1 November 2011; 204: S878 - S883
Role of VP30 Phosphorylation in the Ebola Virus Replication Cycle
Miguel J. Martinez, Valentina A. Volchkova, Hervé Raoul, et al.
1 November 2011; 204: S934 - S940
Ebola Virus Failure to Stimulate Plasmacytoid Dendritic Cell Interferon Responses Correlates With Impaired Cellular Entry
Lawrence W. Leung, Osvaldo Martinez, Olivier Reynard, et al.
1 November 2011; 204: S973 - S977
Filovirus Infection of STAT-1 Knockout Mice
JoLynne Raymond, Steven Bradfute, and Mike Bray
1 November 2011; 204: S986 - S990
Host Response Dynamics Following Lethal Infection of Rhesus Macaques With Zaire ebolavirus
Hideki Ebihara, Barry Rockx, Andrea Marzi, et al.
1 November 2011; 204: S991 - S999
VP24 Is a Molecular Determinant of Ebola Virus Virulence in Guinea Pigs
Mathieu Mateo, Caroline Carbonnelle, Olivier Reynard, et al.
1 November 2011; 204: S1011 - S1020.
Kunjin Virus Replicon-Based Vaccines Expressing Ebola Virus Glycoprotein GP Protect the Guinea Pig Against Lethal Ebola Virus Infection
O. Reynard, V. Mokhonov, E. Mokhonova, J. Leung, et al.
1 November 2011; 204: S1060 - S1065.
Emergence of Divergent Zaire Ebola Virus Strains in Democratic Republic of the Congo in 2007 and 2008
Gilda Grard, Roman Biek, Jean-Jacques Muyembe Tamfum, et al.
1 November 2011; 204: S776 - S784.
Impact of Ebola Mucin-Like Domain on Antiglycoprotein Antibody Responses Induced by Ebola Virus-Like Particles
Osvaldo Martinez, Lee Tantral, Nirupama Mulherkar, et al.
1 November 2011; 204: S825 - S832.
Conserved Proline-Rich Region of Ebola Virus Matrix Protein VP40 Is Essential for Plasma Membrane Targeting and Virus-Like Particle Release
Olivier Reynard, Kirill Nemirov, Audrey Page, et al.
1 November 2011; 204: S884 - S891.
Contribution of Sec61α to the Life Cycle of Ebola Virus
Ayaka Iwasa, Peter Halfmann, Takeshi Noda, et al.
1 November 2011; 204: S919 - S926.
Antibody-Dependent Enhancement of Marburg Virus Infection
Eri Nakayama, Daisuke Tomabechi, Keita Matsuno, et al.
1 November 2011; 204: S978 - S985.
Ebola Virus as a Foodborne Pathogen? Cause for Consideration, but Not Panic
Daniel G. Bausch
15 July 2011; 204 (2): 179 - 181.
Therapeutics of Ebola Hemorrhagic Fever: Whole-Genome Transcriptional Analysis of Successful Disease Mitigation
Judy Y. Yen, Sara Garamszegi, Joan B. Geisbert, et al.
1 November 2011; 204: S1043 - S1052.
Complex Correlates of Protection After Vaccination
Stanley A. Plotkin
15 May 2013; 56 (10): 1458 - 1465.
Interview with Dr. Paul Farmer on the Ebola Outbreak
Open Forum Infectious Diseases Editor-in-Chief Paul Sax, MD, discusses the Ebola pandemic with Paul E. Farmer, MD, PhD, who co-founded Partners in Health – an organization that has been among the first-responders to this latest outbreak.
Containing infectious disease
Michael G. Kurilla
14 July 2014
The emergence of the Middle East Respiratory Syndrome coronavirus
Shauna Milne-Price, Kerri L. Miazgowicz and Vincent J. Munster
9 April 2014
The use of Nanotrap particles for biodefense and emerging infectious disease diagnostics
Nazly Shafagati, Alexis Patanarut, Alessandra Luchini, Lindsay Lundberg, Charles Bailey, Emanuel Petricoin III, Lance Liotta, Aarthi Narayanan, Benjamin Lepene and Kylene Kehn-Hall
20 March 2014
Systems kinomics for characterizing host responses to high-consequence pathogens at the NIH/NIAID Integrated Research Facility-Frederick
Jason Kindrachuk, Shane Falcinelli, Jiro Wada, Jens H. Kuhn, Lisa E. Hensley and Peter B. Jahrling
10 April 2014
Proteomic strategies for the discovery of novel diagnostic and therapeutic targets for infectious diseases
Moushimi Amaya, Alan Baer, Kelsey Voss, Catherine Campbell, Claudius Mueller, Charles Bailey, Kylene Kehn-Hall, Emanuel Petricoin III and Aarthi Narayanan
13 March 2014
Alterations in TLRs as new molecular markers of congenital infections with Human cytomegalovirus?
Wioletta Wujcicka, Jan Wilczyński and Dorota Nowakowska
10 September 2013
Activation of influenza viruses by proteases from host cells and bacteria in the human airway epithelium
Eva Böttcher-Friebertshäuser, Hans-Dieter Klenk and Wolfgang Garten
2 July 2013
Laboratory-acquired lethal infections by potential bioweapons pathogens including Ebola in 2014
8 December 2014
Ebola virus disease managed with blood product replacement and point of care tests in Sierra Leone
T. Nicholson-Roberts , T. Fletcher , P. Rees , S. Dickson , D. Hinsley , M. Bailey , L. Lamb , C. Ardley
First published online: 8 May 2015
Ebola worker’s foot
E.L. Caton , M.S. Bailey , C.A. Bevilacqua , T.E. Fletcher
First published online: 4 April 2015
Infection control during filoviral hemorrhagic fever outbreaks: Preferences of community members and health workers in Masindi, Uganda
Vanessa N. Raabea, Imaam Mutyabac, Paul Roddyd, et. al.
2010; 104 (1): 48-50
A limited outbreak of Ebola haemorrhagic fever in Etoumbi, Republic of Congo, 2005
Dieudonné Nkoghea,b, Mamadou Lamine Konec, Adamou Yadad, and Eric Leroya
2011; 105 (8): 466-472
The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entry
Gerrit Gehring, Katrin Rohrmann, Nkacheh Atenchong, et, al.
2014; 69 (8): 2123-2131
Glycodendritic structures: promising new antiviral drugs
Javier Rojo and Rafael Delgado
September 2004; 54 (3): 579-581
In-vivo activity of antivirals against exotic RNA viral infections
Peter G. Canonico, Meir Kende, Bruno J. Luscri, and John W. Huggins
1984; 14: S27-S41
Treatment of AG129 mice with antisense morpholino oligomers increases survival time following challenge with dengue 2 virus
David A. Stein1, Claire Y.-H. Huang, Shawn Silengo, et. al.
2008; 62 (3): 555-565
Briefing: Ebola – Myths, Realities, and Structural Violence
Annie Wilkinson and Melissa Leach
4 December 2014, Advance Access
Crossing institutional boundaries: mapping the policy process for improved control of endemic and neglected zoonoses in sub-Saharan Africa
Anna Okello, Susan Welburn, and James Smith
7 July 2014
Exploring the international arena of global public health surveillance
2007; 22 (1): 2-12
The implementation of Integrated Disease Surveillance and Response in Uganda: a review of progress and challenges between 2001 and 2007
Luswa Lukwago, Miriam Nanyunja, Nestor Ndayimirije, et. al.
2013; 28 (1): 30-40
Theodore Svoronos, Rose Jallah Macauley and Margaret E. Kruk
27 July 2014
Konzo Outbreak, in the South‐west of the Democratic Republic of Congo, 1996
I. Bonmarin, M. Nunga, and W. A. Perea
2002; 48 (4): 234-238
New players for a new era: responding to the global public health challenges
1997; 19 (2): 171-178
The international Ebola response: heroes and bystanders in the chronicle of an epidemic foretold
Jose M. Martin-Moreno
"A Focus On: Ebola" from Oxford Medicine Online
Alexander van Tulleken
“Filoviruses” from Oxford Textbook of Medicine, Fifth Edition
J. ter Meulen
“Viral Haemorrhagic Fevers” from OSH Manual of Childhood Infections: The Blue Book
“Emerging and re-emerging infections” from Oxford Textbook of Global Public Health
David L. Heymann
“World Health Organization” from Max Planck Encyclopedia of Public International Law
“History of Public Health”
L. Fleming Fallon
Ethical issues in managing the current Ebola crisis
August 14th, 2014
The Responsibility to Protect in the Ebola outbreak
September 22nd, 2014
What will it take to reduce infections in the hospital?
October 17th, 2014
How much are nurses worth?
Sandy Summers and Harry Jacobs Summers
October 22nd, 2014
October 24th, 2014
Religious organizations in the public health paradigm
October 26th, 2014
Lessons from the heart: listening after Ebola
Mark Cave and Stephen M. Sloan
October 25th, 2014
Global solidarity and Cuba’s response to the Ebola outbreak
November 15th, 2014
Ebola: the epidemic’s next phase
December 13th, 2014
Traveling patients, traveling disease: Ebola is just the tip of the iceberg
I. Glenn Cohen
December 14th, 2014